Shin Lee

Dr. Shin Lee


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
SLShin Lee
Shin Lee
KFKei Fujita
Kei Fujita
TMTetsuji Morishita
Tetsuji Morishita
ENEiju Negoro
Eiju Negoro
KOKana Oiwa
Kana Oiwa
TYTakahiro Yamauchi
Takahiro Yamauchi

15 December 2020 in The Oncologist
Verified
Journal Article
Open access
PDF file
KOKana Oiwa
Kana Oiwa
KFKei Fujita
Kei Fujita
SLShin Lee
Shin Lee
TMTetsuji Morishita
Tetsuji Morishita
HTHikaru Tsukasaki
Hikaru Tsukasaki
TYTakahiro Yamauchi
Takahiro Yamauchi
Background: The management of severe adverse events (AEs) is important in safely and effectively providing chemotherapy to older adults with diffuse large B-cell lymphoma (DLBCL). However, reports on simple and DLBCL-specific predictive models for treatment-related toxicity in elderly individuals are scarce. The aim of this study was to examine the usefulness of Geriatric 8 (G8) in predicting treatment-related severe AEs, nonhematological toxicity, and febrile neutropenia in older adults with DLBCL in real-world practice. Materials and Methods: We conducted a multicenter, retrospective study on 398 consecutive patients with DLBCL (aged ≥65 years) who received standard therapy at three centers in Japan (University of Fukui Hospital, the Fukui Prefectural Hospital, and the Japanese Red Cross Fukui Hospital), between 2007 and 2017. Result: Multivariate logistic analysis demonstrated that the G8 score was an independent predictive factor for severe AEs. Moreover, a logistic regression model with restricted cubic spline showed a nonlinear association between the incidence of severe AEs and the G8 score. According to receiver operating characteristic analysis, the most discriminative cutoff value of the G8 for the incidence of severe AEs was 11, with an area under the curve value of 0.670. AEs occurred most often in the first course of chemotherapy and decreased as the course progressed. Conclusion: The G8 score, an easy-to-use geriatric assessment tool, can be a useful prediction model of treatment-related severe AEs during standard therapy in older adults with DLBCL. Implications for Practice: In older patients with diffuse large B-cell lymphoma (DLBCL), to accurately predict the risk of severe adverse events (AEs) in advance is essential for safe and effective treatment. This study demonstrated that the Geriatric 8 score, a simple and established geriatric assessment tool, indicated a high predictive ability for occurrence of therapy-related severe AEs in elderly patients with DLBCL who were treated with standard treatment.

26 May 2021 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
SLShin Lee
Shin Lee
KFKei Fujita
Kei Fujita
TMTetsuji Morishita
Tetsuji Morishita
KOKana Oiwa
Kana Oiwa
HTHikaru Tsukasaki
Hikaru Tsukasaki
TYTakahiro Yamauchi
Takahiro Yamauchi

8 August 2017 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
SLShin Lee
Shin Lee
TYTakahiro Yamauchi
Takahiro Yamauchi
NINorito Ishii
Norito Ishii
THTakashi Hashimoto
Takashi Hashimoto
KKKeiichi Kinoshita
Keiichi Kinoshita
KKKenichi Kamiya
Kenichi Kamiya

1 July 2019 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SLShin Lee
Shin Lee
HTHikaru Tsukasaki
Hikaru Tsukasaki
TYTakahiro Yamauchi
Takahiro Yamauchi

8 July 2023 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
KFKei Fujita
Kei Fujita
SLShin Lee
Shin Lee
TMTetsuji Morishita
Tetsuji Morishita
ENEiju Negoro
Eiju Negoro
KOKana Oiwa
Kana Oiwa
TYTakahiro Yamauchi
Takahiro Yamauchi